The effect of histidine-tryptophan-ketoglutarate cardioplegia alone or combined with preoperative infusion of levosimendan on vasoactive inotropic score in patients with poor cardiac function undergoing coronary artery bypass grafting

References

• Topkara VK, Cheema FH, Kesavaramanujam S, et al. Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005;112(9_supplement):I–344. doi: 10.1161/CIRCULATIONAHA.104.526277
   Web of Science ®Google Scholar
• Royster RL, Butterworth Iv JF, Prough DS, et al. The wake. Forest University Medical Center;1991. http://journals.lww.com/anesthesia-analgesia.
   Google Scholar
• De Hert SG. Levosimendan: clinical applications. Rev Mex de Anestesiol. 2010;33(S1):248.
   Google Scholar
• Sorsa T, Heikkinen S, Abbott MB, et al. Binding of levosimendan, a calcium sensitizer, to cardiac troponin C. J Biol Chem. 2001;276(12):9337–9343. doi: 10.1074/jbc.M007484200
   PubMed Web of Science ®Google Scholar
• Antila S, Sundberg S, Lehtonen LA. Clinical pharmacology of levosimendan. Clin Pharmacokinet. 2007;46(7):535–52. doi: 10.2165/00003088-200746070-00001; PMID: 17596101.
   PubMed Web of Science ®Google Scholar
• Tasouli A, Papadopoulos K, Antoniou T, et al. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use. Eur J Cardiothorac Surg. 2007;32(4):629–633. doi: 10.1016/j.ejcts.2007.07.010
   PubMed Web of Science ®Google Scholar
• Guarracino F, Heringlake M, Cholley B, et al. Use of Levosimendan in cardiac surgery: an update after the LEVO-CTS, CHEETAH, and LICORN trials in the light of clinical practice. J Cardiovasc Pharmacol. 2018 Jan;71(1):1–9. PMID: 29076887; PMCID: PMC5768218. doi: 10.1097/FJC.0000000000000551
   PubMed Web of Science ®Google Scholar
• Li ZS, Wang K, Pan T, et al. The evaluation of levosimendan in patients with acute myocardial infarction related ventricular septal rupture undergoing cardiac surgery: a prospective observational cohort study with propensity score analysis. BMC Anesthesiol. 2022;22(1):135. doi: 10.1186/s12871-022-01663-z
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Oba K, Matsui Y, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass. J Anesth. 2018;32(2):167–173. doi: 10.1007/s00540-018-2447-2
   PubMed Web of Science ®Google Scholar
• Velazquez EJ, Lee KL, Jones RH, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374(16):1511–1520. doi: 10.1056/NEJMoa1602001
   PubMed Web of Science ®Google Scholar
• Kunadian V, Zaman A, Qiu W. Revascularization among patients with severe left ventricular dysfunction: a meta‐analysis of observational studies. European J Heart Fail. 2011;13(7):773–784. doi: 10.1093/eurjhf/hfr037
   PubMed Web of Science ®Google Scholar
• Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364(17):1607–1616. doi: 10.1056/NEJMoa1100356
   PubMed Web of Science ®Google Scholar
• Bradić J, Andjić M, Novaković J, et al. Cardioplegia in open heart surgery: age matters. J Clin Med. 2023;12(4):1698. doi: 10.3390/jcm12041698
   PubMed Web of Science ®Google Scholar
• Albadrani M. Histidine–tryptophan–ketoglutarate solution versus multidose cardioplegia for myocardial protection in cardiac surgeries: a systematic review and meta-analysis. J Cardiothorac Surg. 2022;17(1):133. doi: 10.1186/s13019-022-01891-x
   PubMed Web of Science ®Google Scholar
• Duan L, Hu GH, Wang E, et al. Del Nido versus HTK cardioplegia for myocardial protection during adult complex valve surgery: a retrospective study. BMC Cardiovasc Disord. 2021;21(1):1–10. doi: 10.1186/s12872-021-02411-w
   PubMed Web of Science ®Google Scholar
• El-Morsy GZ, Abo-Haded HM, Abdullah HM, et al. Does type of cardioplegia affect myocardial and cerebral outcome in pediatric open cardiac surgeries? Ain-Shams J Anaesth. 2014;7(2):242. doi: 10.4103/1687-7934.133451
   Google Scholar
• Chen Y, Shi J, Xia TC, et al. Preservation solutions for kidney transplantation: history, advances and mechanisms. Cell Transplant. 2019;28(12):1472–1489. doi: 10.1177/0963689719872699
   PubMed Web of Science ®Google Scholar
• Aarsæther E, Stenberg TA, Jakobsen Ø, et al. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas’ and histidine-tryptophan-ketoglutarate cardioplegia–an experimental comparative study in pigs. Interact Cardiovasc Thorac Surg. 2009;9(4):635–639. doi: 10.1510/icvts.2009.208231
   PubMedGoogle Scholar
• Wang Q, Zuurbier CJ, Huhn R, et al. Pharmacological cardioprotection against ischemia reperfusion injury—the search for a clinical effective therapy. Cells. 2023;12(10):1432. doi: 10.3390/cells12101432
   PubMed Web of Science ®Google Scholar
• Goodman LS, Gilman A. The pharmacological basis of therapeutics. The Pharmacological Basis Of Therapeutics. 1956;1(33):xiii–1831.
   Google Scholar
• Altenberger J, Parissis JT, Ulmer H, et al. Rationale and design of the multicentre randomized trial investigating the efficacy and safety of pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep study). Eur J Heart Fail. 2010;12(2):186–192. doi: 10.1093/eurjhf/hfp189
   PubMed Web of Science ®Google Scholar
• Di Molfetta P, Gregorini R, Fiore C, et al. Is there still room for the prophylactic use of levosimendan in cardiac surgery? Ann Thorac Surg. 2018;106(5):1590. doi: 10.1016/j.athoracsur.2018.05.007
   PubMed Web of Science ®Google Scholar
• De Hert SG, Lorsomradee S, Cromheecke S, et al. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesthesia & Analgesia. 2007;104(4):766–773. doi: 10.1213/01.ane.0000256863.92050.d3
   PubMed Web of Science ®Google Scholar
• Jiménez-Rivera JJ, Álvarez-Castillo A, Ferrer-Rodríguez J, et al. Preconditioning with levosimendan reduces postoperative low cardiac output in moderate-severe systolic dysfunction patients who will undergo elective coronary artery bypass graft surgery: a cost-effective strategy. J Cardiothorac Surg. 2020;15(1):108. doi: 10.1186/s13019-020-01140-z
   PubMed Web of Science ®Google Scholar
• Kolseth SM, Nordhaug DO, Stenseth R, et al. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function. Eur J Cardiothorac Surg. 2009;36(6):1024–1030. doi: 10.1016/j.ejcts.2009.05.001
   PubMed Web of Science ®Google Scholar
• Sharma P, Malhotra A, Gandhi S, et al. Preoperative levosimendan in ischemic mitral valve repair. Asian Cardiovasc Thorac Ann. 2014;22(5):539–545. doi: 10.1177/0218492313499352
   PubMedGoogle Scholar
• Sanfilippo F, Knight JB, Scolletta S, et al. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis. Crit Care. 2017;21(1):1–10. doi: 10.1186/s13054-017-1849-0
   PubMedGoogle Scholar
• Lehmann A, Kiessling AH, Isgro F, et al. Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization. Eur J Anaesthesiol. 2008;25(3):224–229. doi: 10.1017/S0265021507002761
   PubMed Web of Science ®Google Scholar
• Levin RL, Degrange MA, Porcile R, et al. The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome. Revista Española de Cardiología (English Edition). 2008;61(5):471–479. doi: 10.1016/S1885-5857(08)60160-7
   PubMed Web of Science ®Google Scholar
• Tritapepe L, De Santis V, Vitale D, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting—a pilot study. Br J Anaesth. 2006;96(6):694–700. doi: 10.1093/bja/ael082
   PubMed Web of Science ®Google Scholar
• Tritapepe L, De Santis V, Vitale D, et al. Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery. Br J Anaesth. 2009;102(2):198–204. doi: 10.1093/bja/aen367
   PubMed Web of Science ®Google Scholar
• Eriksson HI, Jalonen JR, Heikkinen LO, et al. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function. Ann Thorac Surg. 2009;87(2):448–454. doi: 10.1016/j.athoracsur.2008.10.029
   PubMed Web of Science ®Google Scholar
• Habib M, Torky M, Abdelwahab A, et al. Impact of Levosimendan on high sensitivity cardiac troponin-T after valvular heart surgery: a randomized clinical trial. Egypt Cardiothoracic Surg. 2022;4(5):73–79. doi: 10.35810/ects.v4i5.238
   Google Scholar
• Mardiguian S, Kivikko M, Heringlake M, et al. Cost-benefits of incorporating levosimendan into cardiac surgery practice: German base case. J Med Econ. 2016;19(5):506–514. doi: 10.3111/13696998.2015.1136312
   PubMed Web of Science ®Google Scholar
• Hendrich J, Mardiguian S, Smare C, et al. Cost benefits of incorporating levosimendan into cardiac surgery practice: German base case. Value Health. 2015;18(7):A390. doi: 10.1016/j.jval.2015.09.862
   Google Scholar
• Davidson SM, Ferdinandy P, Andreadou I, et al. Multitarget strategies to reduce myocardial ischemia/reperfusion injury: JACC review topic of the week. J Am Coll Cardiol. 2019;73(1):89–99. doi: 10.1016/j.jacc.2018.09.086
   PubMed Web of Science ®Google Scholar
• Chiari P, Mewton N, Maucort-Boulch D, et al. Multimodal strategy for myocardial protection during cardiac surgery: the ProCCard study. J Am Coll Cardiol. 2021;77(6):827–829. doi: 10.1016/j.jacc.2020.12.020
   PubMed Web of Science ®Google Scholar